Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on June 25, 2015. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Variability in the efficacy of oral cancer screening according to risk of oral cancer within Oral Cancer Screening Trials

Awarded
N02CP52620-24Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Cancer Institute intends to award a firm fixed price, sole source contract to the International Agency for Research on Cancer to perform statistical analyses using data from the Kerala Oral Cancer Screening Trial. The project aims to develop and utilize risk prediction models to investigate how the efficacy of visual oral cancer screening varies based on a participant's predicted risk level. This research builds upon previous findings that indicated screening benefits were primarily observed in high-risk individuals, such as tobacco and alcohol users. The International Agency for Research on Cancer is identified as the sole source for this procurement because they conducted the original trial and maintain exclusive access to the necessary data. This acquisition follows simplified acquisition procedures under NAICS code 541380. While the agency is seeking a sole source award to avoid disruption to the ongoing project, interested parties were given until July 9, 2015, to submit capability statements for consideration.

General Info

NCI sole source contract for IARC to perform Kerala Oral Cancer statistical analyses.

Agency

N/A

Contract Value

$35,000

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609, BETHESDA, MD, 20892, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Kimesha LeakeContract Specialist
Terry GallowayContracting Officer

Full Description

Show more
The National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Epidemiology and Biostatistics Program (EBP), Infections and Immunoepidemiology Branch (IIB) plans to procure on a sole source statistical analyses using data from IARC's Kerala Oral Cancer Screening Trial to investigate variability in the efficacy of screening according to participants' predicted risk of oral cancer from the International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69372 Lyon cedex 08, France. This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 541380 and the business size standard is 500 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. It has been determined there are no opportunities to acquire green products or services for this procurement. Oral cancers are ideal candidates for screening, early detection, and secondary prevention given their amenability for visual inspection and specimen collection as well as the availability of recognized precursor lesions. Only one randomized trial to date has investigated whether visual screening for oral cancer precursors or cancer reduced oral cancer mortality. This community-based, cluster-randomized trial of 191,872 individuals conducted in Kerala, India, showed sustained reduction in oral cancer mortality over 15 years of follow-up among screened individuals as compared with individuals who were not screened. More importantly, the trial showed that the benefit of visual screening was observed almost exclusively among individuals with traditional oral cancer risk factors-cigarette smokers, tobacco chewers, or alcohol users. The results of the Kerala screening trial underscore that the efficacy of visual screening for oral cancer varies according to an individual's baseline risk of oral cancer. In that, individuals at high risk for oral cancer (e.g. smokers, chewers, and alcohol users) experienced all of the benefit from screening, while individuals at low-risk for oral cancer did not experience any benefit from screening. It is likely that even among the high risk group of smokers, chewers, and alcohol users, there would be further variability in the efficacy of visual screening, with the benefits accruing among the highest risk individuals. The NCI proposes to enter into a contract with researchers at the International Agency for research on Cancer to develop and utilize oral cancer risk prediction models to identify a subgroup of individuals in the Kerala screening trial who experienced the maximum benefit from visual inspection. IARC is the only source of data on the Kerala oral cancer screening trial. There has only been one trial conducted to date on this topic, and this trial was conducted by IARC. IARC is necessary to continue an ongoing project; a change would be disruptive to the experiment. This notice is not a request for competitive quotation. However, if any interested party, especially small businesses, believes it can meet the above requirement, it may submit a capability statement, proposal, or quotation, which shall be considered by the agency. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 3:00 PM EST, on July 9, 2015. All responses and questions must be in writing and faxed +1 (555) 000-0000 or emailed to Kimesha Leake, Contract Specialist OR via electronic mail at contact@example.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractors must be registered and have valid certification in the System for Award Management (SAM) through sam.gov. Reference: N02CP52620-24 on all correspondence.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS